These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23675686)

  • 1. Early necrotizing fasciitis following initiation of mycophenolate mofetil in two patients with bullous pemphigoid.
    Sené T; Régnier S; Robert N; Dupuy A; Morel P; Tancrede E; Rybojad M
    Int J Dermatol; 2014 Mar; 53(3):e236-9. PubMed ID: 23675686
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous pemphigoid treated with mycophenolate mofetil.
    Böhm M; Beissert S; Schwarz T; Metze D; Luger T
    Lancet; 1997 Feb; 349(9051):541. PubMed ID: 9048797
    [No Abstract]   [Full Text] [Related]  

  • 4. Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy.
    Fox JC; Kenkare S; Petronic-Rosic V; Soltani K; Sethi A
    Pediatr Dermatol; 2010; 27(5):537-9. PubMed ID: 20807355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous pemphigoid associated with type 1 diabetes mellitus responsive to mycophenolate mofetil.
    Sakanoue M; Kawai K; Kanekura T
    J Dermatol; 2012 Oct; 39(10):884-5. PubMed ID: 22168231
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful therapy for bullous pemphigoid with mycophenolate mofetil.
    Nousari HC; Griffin WA; Anhalt GJ
    J Am Acad Dermatol; 1998 Sep; 39(3):497-8. PubMed ID: 9738791
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy.
    Grundmann-Kollmann M; Kaskel P; Leiter U; Krähn G; Behrens S; Peter RU; Kerscher M
    Arch Dermatol; 1999 Jun; 135(6):724-5. PubMed ID: 10376713
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effectiveness of azathioprine or mycophenolate mofetil as an adjuvant for the treatment of bullous pemphigoid.
    Bystryn JC
    Arch Dermatol; 2008 Jul; 144(7):946. PubMed ID: 18645153
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of refractory antilaminin γ1 pemphigoid successfully treated with dexamethasone and mycophenolate mofetil.
    Zhiliang L; Xiaodong Z; Peiying J; Suying F; Baoxi W
    Int J Dermatol; 2015; 54(5):e194-6. PubMed ID: 25773159
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of anti-laminin γ1 pemphigoid with mycophenolate mofetil.
    Gawaz A; Metzler G; Hertl M; Hashimoto T; Schaller M
    J Dtsch Dermatol Ges; 2015 Jul; 13(7):696-7. PubMed ID: 26058852
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.
    Ratnam KV
    Singapore Med J; 2001 Oct; 42(10):482-4. PubMed ID: 11874153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mycophenolate mofetil as effective therapy option in scarring pemphigoid].
    Elser I; Selimovic D; Ruzicka T; Kuhn A; Megahed M
    Hautarzt; 2003 Oct; 54(10):981-4. PubMed ID: 14513249
    [No Abstract]   [Full Text] [Related]  

  • 13. Refractory antilaminin γ1 pemphigoid successfully treated with intravenous immunoglobulin and mycophenolate mofetil.
    Alloo A; Strazzula L; Rothschild B; Hawryluk E; Levine D; Hoang MP; Koga H; Hashimoto T; Kroshinsky D
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1401-3. PubMed ID: 24397852
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil therapy for pediatric bullous pemphigoid.
    Seminario-Vidal L; Sami N; Miller J; Theos A
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy for autoimmune bullous diseases.
    Meurer M
    Clin Dermatol; 2012; 30(1):78-83. PubMed ID: 22137230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset of acquired haemophilia A after omalizumab treatment in severe bullous pemphigoid - a report on two cases successfully treated with mycophenolate mofetil.
    Mangin MA; Lienhart A; Gouraud A; Roux S; Hodique F; Jouen F; Balme B; Dalle S; Debarbieux S
    Ann Dermatol Venereol; 2021 Mar; 148(1):57-59. PubMed ID: 33461795
    [No Abstract]   [Full Text] [Related]  

  • 17. Bullous pemphigoid associated with acute renal allograft rejection.
    Sofi AA; Gottwald L; Bohman K; Kaw D
    Transplantation; 2010 Feb; 89(3):368-9. PubMed ID: 20145531
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M; David M; Mimouni D
    Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of bullous pemphigoid with enteric-coated mycophenolate sodium.
    Tursen U; Guney A; Kaya T; Ikizoglu G
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):542-4. PubMed ID: 17373988
    [No Abstract]   [Full Text] [Related]  

  • 20. Necrotizing fasciitis in a patient with bullous pemphigoid treating with systemic steroid.
    Ekiz Ö; Şen BB; Rifaioğlu EN; Özgür T; İnan MU; Doğramacı ÇA
    Cutan Ocul Toxicol; 2013 Sep; 32(3):252-4. PubMed ID: 23350559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.